Acumen Pharmaceuticals
Balance Sheet

Last updated:

The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Acumen Pharmaceuticals's balance sheet done over the years? Its assets were worth $310,125,000 last year, which is more than in the previous period. 14% of Acumen Pharmaceuticals’s total assets is currently financed by debt. Its liabilities reached the amount of $43,152,000, which means an increase by 452% compared compared to last year.

Debt to Assets

Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS): Debt to assets
2019 7322000 18.74M 255.97%
2020 44429000 63.02M 141.84%
2021 230330000 5.14M 2.23%
2022 196587000 7.81M 3.97%
2023 310125000 43.15M 13.91%

ABOS Balance Sheet (2019 – 2023)

2023 2022 2021 2020 2019
Assets
Current assets:
Cash and cash equivalents
66.88M130.10M122.16M43.77M6.55M
Short term investments
176.63M47.50M72.07M00
Net receivables
225K-199-83109K30K
Inventory
01998391K49K
Other current assets
2.86M2.72M4.42M452K547K
Total current assets
246.61M180.32M198.66M44.42M7.17M
Non-current assets:
Property, Plant and Equipment
503K270K36K00
Goodwill
00000
Intangible assets
00000
Long term investments
62.55M15.83M31.61M00
Other non-current assets
454K151K14K0144K
Total non-current assets
63.51M16.25M31.66M0144K
Total assets
310.12M196.58M230.33M44.42M7.32M
Liabilities
Current liabilities:
Accounts payable
Deferred revenue
00000
Short term debt
1.73M105K000
Total current liabilities
12.97M7.81M5.14M6.36M1.34M
Non-current liabilities:
Long term debt
27.62M0000
Deferred tax
00000
Other non-current liabilities
2.56M1.74M4.05M00
Total non-current liabilities
30.18M1.74M4.05M56.65M17.4M
Total liabilities
43.15M7.81M5.14M63.02M18.74M
Data sourceData sourceData source